Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Examination format at UFS to change
2011-04-22

A new examination format is to be followed from the coming examination in May 2011 at the University of the Free State (UFS). According to this, the additional examination opportunity is to follow on the heels of the main examination.

According to the new format, students who qualify to write examinations will be compelled to write their papers during the first opportunity, and will only be allowed to write an additional examination once their applications for this examination have been approved. Students who qualify for re-assessment and special examinations will automatically be admitted to the additional examination and will therefore be exempt from the application process.
 
According to Dr Saretha Brüssow, Head: Teaching and Learning at the UFS, the Examination Committee requested the investigation of the double examination which applied previously, due to the pressure it caused on the university systems.
 
She said that, besides this release of pressure on systems such as the registration process, the back-to-back semester-based examination system might also lead to a possible improvement of the academic success rate, due to the shorter time span between the first and the second examination opportunities.
 
Students attended classes poorly in the past due to the second examination opportunity, which took place during the following semester after classes had resumed. “In some cases it is specifically the student at risk, who cannot afford to miss classes, who makes use of the second examination opportunity.”
 
Dr. Brüssow said the registration process was also affected by the previous format due to students who wanted to receive their results first before they registered. Other delays which occurred as a result of the second examination opportunity, were the first annual graduation ceremony which took place late in the year, the awarding of bursaries, and the finalisation of residence accommodation. Adding on to this problematic nature is students who occupy residences in the following academic year without a formal application in order to write during the second examination opportunity in January.
 
The new format is applicable to all students, except those in the Faculty of Health. Main and South Campus students can direct enquiries to addexam@ufs.ac.za. Qwaqwa Campus students should email addexam@qwa.ufs.ac.za.  Information on the new examination format is also available on www.ufs.ac.za.
 
 
Media Release
21 April 2011
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept